Home › Cardiovascular Disease › Michigan › Lansing
Cardiovascular Disease clinical trials in Lansing, MI
3 studies for Cardiovascular Disease are looking for participants at sites in and around Lansing (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- UMH-Sparrow Clinical Research Institute, Lansing
Product Surveillance Registry
RecruitingObservational study
- Lansing, Lansing
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Lansing
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- San Francisco, CA18 studies
Other studies in Lansing
- Lung Cancer11 studies
- Prostate Cancer10 studies
- Breast Cancer10 studies
- Non-Small Cell Lung Cancer9 studies
- Cancer (all types)6 studies
- Laryngeal Cancer5 studies
- Bladder Cancer5 studies
- Disorders of Excessive Somnolence5 studies
- Colorectal Cancer4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Colon Cancer4 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.